Global Cardiac Biomarkers Diagnostics Industry Research 2024-2029: Rising Prevalence of CVD and High Sensitivity POCT Driving Transformational Growth [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Research and Markets Tue, February 18, 2025 at 11:39 AM GMT+1 5 min read Company Logo Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Global Cardiac Biomarkers Diagnostics Industry, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This research service provides an overview of the global cardiac biomarkers diagnostics industry and a 6-year global market revenue forecast from 2024 to 2029. The geographical scope covers four regions: North America, Europe, Asia-Pacific, and the Middle East, North Africa, and South Asia (MENASA) and Latin America. The market is moderately competitive driven by advances in biomarkers assays and technology alongside a continuous push for enhanced accuracy and high sensitivity of assays. Six players dominate the market: Roche Diagnostics, Abbott Rapid Diagnostics (formally Alere), Quidel Corporation, bioMerieux, Siemens Healthineers, and Danaher Corporation. There are limited players in lab analyzers, making this segment con
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- 2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income [Yahoo! Finance]Yahoo! Finance
- ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE:ABT) Receives FDA Approval For Coronary IVL System Trial In US [Yahoo! Finance]Yahoo! Finance
- Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/25 - In-Line
ABT
Sec Filings
- 3/14/25 - Form ARS
- 3/14/25 - Form DEFA14A
- 3/14/25 - Form DEF
- ABT's page on the SEC website